Testing a new version of an obesity treatment pill
Part of Hormones & metabolism clinical trials.
This trial compares two versions of the study drug HRS9531 in people with overweight or obesity to see which one works better in the body. It may help find a more effective treatment for weight management.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 55 years old.
- You weigh at least 65 kg (about 143 lbs) and have a BMI between 24 and 35.
- Your weight has been stable (not changed by more than 5 kg) in the last 3 months.
- You are generally healthy, with no serious medical conditions like heart disease, uncontrolled high blood pressure, or stomach problems.
- You do not smoke heavily, drink a lot of alcohol, or use illegal drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication called HS-20094 for people who are overweight or have obesity. It is designed to help with weight loss and will last for several months to see how safe and effective the medicine is.
This study tests the safety of a new oral medication called HRS-1597 in two groups: healthy people with normal weight and people who are overweight or obese. It will help determine if the drug is safe and how the body processes it.
This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.
This trial tests an oral medication, HRS9531, to help overweight or obese adults lose weight. It may be an option if you have been unable to lose enough weight through diet and exercise alone.
This study tests a new weight-loss medicine called HRS-1596. It is given as a tablet to see if it is safe and how well it works. The study first gives a single dose to healthy adults, then multiple doses to people with obesity.
This study tests how a new tablet (called HRS9531) is absorbed and processed by the body under different conditions (like with or without food). It is for healthy volunteers to find the best way to take the tablet.
Hear when a new Overweight or Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.